|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(2R)-2-(3-fluoro-4-{3-[(hexylcarbamoyl)oxy]phenyl}phenyl)propanoic acid |
Synonyms ![]() |
compound (-)-10r [PMID: 26774927] | example 19 [WO2014023643] |
Comments |
(R)-ARN2508 is an experimental inhibitor of fatty acid amide hydrolase (FAAH) [2], claimed in patent WO2014023643 [1]. The compound series developed by Migliore et al. (2015) [2] is based on a hybrid scaffold combining structural motifs of the FAAH inhibitor URB597 and the COX inhibitor flurbiprofen. The (S) enantiomer ((S)-ARN2508) inhibits both FAAH and COX enzyme activities, whereas this (R) enantiomer only inhibits FAAH. |
Database Links ![]() |
|
GtoPdb PubChem SID | 310264778 |
PubChem CID | 117072557 |
Search Google for chemical match using the InChIKey | USQOVYLRWBOSQC-OAHLLOKOSA-N |
Search Google for chemicals with the same backbone | USQOVYLRWBOSQC |
Search UniChem for chemical match using the InChIKey | USQOVYLRWBOSQC-OAHLLOKOSA-N |
Search UniChem for chemicals with the same backbone | USQOVYLRWBOSQC |